Cited by 510RNA Research and SplicingGenetic Neurodegenerative DiseasesMuscle Physiology and Disorders

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy

Lin, Xiaoyan, Miller, Jill W., Mankodi, Ami, Kanadia, Rahul N., Yuan, Yuan, Moxley, Richard T., Swanson, Maurice S., Thornton, Charles A.·2006·Human Molecular Genetics

DOI 10.1093/hmg/ddl132

Open this paper in CoChat — free account

Abstract

In myotonic dystrophy (DM), expression of RNA containing expanded CUG or CCUG repeats leads to misregulated alternative splicing of pre-mRNA. The repeat-bearing transcripts accumulate in nuclear foci, together with proteins in the muscleblind family, MBNL1 and MBNL2. In transgenic mice that express expanded CUG repeats, we show that the splicing defect selectively targets a group of exons that share a common temporal pattern of developmental regulation. These exons undergo a synchronized splicing switch between post-natal day 2 and 20 in wild-type mice. During this post-natal interval, MBNL1 protein translocates from a predominantly cytoplasmic to nuclear distribution. In the absence of MBNL1, these physiological splicing transitions do not occur. The splicing defect induced by expanded CUG repeats in mature muscle fibers is closely reproduced by deficiency of MBNL1 but not by deficiency of MBNL2. A parallel situation exists in human DM type 1 and type 2. MBNL1 is depleted from the muscle nucleoplasm because of sequestration in nuclear foci, and the associated splicing defects are remarkably similar to those observed in MBNL1 knockout mice. These results indicate that MBNL1 participates in the post-natal remodeling of skeletal muscle by controlling a key set of developmentally regulated splicing switches. Sequestration of MBNL1, and failure to maintain these splicing transitions, has a pivotal role in the pathogenesis of muscle disease in DM.

Integrity signals

Registry

Crossref · 10.1093/hmg/ddl132

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
Ultraconserved Elements in the Human Genome
Bejerano, G., Pheasant, M., Makunin, I., Stephen, S., Kent, W. J., Mattick, J. S., & Haussler, D. (2004) · Science · doi:10.1126/science.1098119 · Cited by 1,732
Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9
Liquori, C. L., Ricker, K., Moseley, M. L., Jacobsen, J. F., Kreß, W., Naylor, S. L., Day, J., & Ranum, L. P. W. (2001) · Science · doi:10.1126/science.1062125 · Cited by 1,254
Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy
Miller, J. W., Urbinati, C. R., Teng‐umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A., & Swanson, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937
Self-citation
Disruption of Splicing Regulated by a CUG-Binding Protein in Myotonic Dystrophy
Philips, A. V., Timchenko, L., & Cooper, T. A. (1998) · Science · doi:10.1126/science.280.5364.737 · Cited by 818
The Polo kinase Plk4 functions in centriole duplication
Habedanck, R., Stierhof, Y., Wilkinson, C. J., & Nigg, E. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1320 · Cited by 809
Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy
Savkur, R. S., Philips, A. V., & Cooper, T. A. (2001) · Nature Genetics · doi:10.1038/ng704 · Cited by 795
A Muscleblind Knockout Model for Myotonic Dystrophy
Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W., & Swanson, M. S. (2003) · Science · doi:10.1126/science.1088583 · Cited by 743
Self-citation
Myotonic Dystrophy in Transgenic Mice Expressing an Expanded CUG Repeat
Mankodi, A. K., Logigian, E. L., Callahan, L. M., McClain, C., White, R. J., Henderson, D., Krym, M., & Thornton, C. A. (2000) · Science · doi:10.1126/science.289.5485.1769 · Cited by 738
Self-citation
Expanded CUG Repeats Trigger Aberrant Splicing of ClC-1 Chloride Channel Pre-mRNA and Hyperexcitability of Skeletal Muscle in Myotonic Dystrophy
Mankodi, A. K., Takahashi, M. P., Jiang, H. N., Beck, C. L., Bowers, W. J., Moxley, R. T., Cannon, S. C., & Thornton, C. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00563-4 · Cited by 672
Self-citation

Flagged first, then by citations

Show all 35 references

Sorted by citations

Items 301–400 of 509

Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives
Rahm, L., Hale, M. A., Raaijmakers, R. H. L., Quiñones, A. M., Patki, T., Johnson, N. E., van Bokhoven, H., & Mul, K. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01139-x · Cited by 24
Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes
Cerro-Herreros, E., Chakraborty, M., Pérez‐Alonso, M., Artero, R. D., & Llamusí, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-02829-3 · Cited by 20
Transcriptome Analysis in a Primary Human Muscle Cell Differentiation Model for Myotonic Dystrophy Type 1
Todorow, V., Hintze, S., Kerr, A. R. W., Hehr, A., Schoser, B. G. H., & Meinke, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168607 · Cited by 20
The molecular pathogenesis of repeat expansion diseases
Fujino, Y., & Nagai, Y. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200143 · Cited by 20
Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner
Misquitta, N. S., Ravel‐Chapuis, A., & Jasmin, B. J. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac222 · Cited by 20
The emerging significance of splicing in vertebrate development
Olthof, A. M., White, A. K., & Kanadia, R. (2022) · Development · doi:10.1242/dev.200373 · Cited by 20
Self-citation
Age of Onset of RNA Toxicity Influences Phenotypic Severity: Evidence from an Inducible Mouse Model of Myotonic Dystrophy (DM1)
Gladman, J. T., Mandal, M., Srinivasan, V., & Mahadevan, M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072907 · Cited by 20
Quantitative Studies of Muscleblind Proteins and Their Interaction With TCF4 RNA Foci Support Involvement in the Mechanism of Fuchs' Dystrophy
Rong, Z., Hu, J., Corey, D. R., et al. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27641 · Cited by 20
AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1
Stępniak-Konieczna, E., Konieczny, P., Cywoniuk, P., Dluzewska, J., & Sobczak, K. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa007 · Cited by 21
An engineered RNA binding protein with improved splicing regulation
Hale, M. A., Richardson, J. I., Day, R. C., McConnell, O. L., Arboleda, J. D., Wang, E. T., & Berglund, J. A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1304 · Cited by 19
Cellular Senescence and Aging in Myotonic Dystrophy
Hasuike, Y., Mochizuki, H., & Nakamori, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042339 · Cited by 22
Genomic profiling screens small molecules of metastatic prostate carcinoma
Xu, A., & Sun, S. (2015) · Oncology Letters · doi:10.3892/ol.2015.3472 · Cited by 19
Identification of erythroid‐enriched gene expression in the mouse embryonic yolk sac using microdissected cells
Redmond, L. C., Dumur, C. I., Archer, K. J., et al. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21426 · Cited by 19
Muscleblind-like1 undergoes ectopic relocation in the nuclei of skeletal muscles in myotonic dystrophy and sarcopenia
Malatesta, M., Giagnacovo, M., Costanzo, M., Cisterna, B., Cardani, R., & Meola, G. (2013) · European Journal of Histochemistry · doi:10.4081/ejh.2013.e15 · Cited by 19
Pathogenic RNAs in microsatellite expansion disease
Shin, J., Charizanis, K., & Swanson, M. S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.07.079 · Cited by 20
Self-citation
Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes
Dastidar, S., Majumdar, D., Tipanee, J., Singh, K., Klein, A. F., Furling, D., Chuah, M., & VandenDriessche, T. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.08.004 · Cited by 19
Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy
Hu, N., Kim, E., Antoury, L., & Wheeler, T. M. (2023) · Nature Communications · doi:10.1038/s41467-023-37619-1 · Cited by 19
A Conserved Motif Controls Nuclear Localization of Drosophila Muscleblind
Fernández‐Costa, J. M., & Artero, R. D. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0089-9 · Cited by 24
A fly model for the CCUG-repeat expansion of myotonic dystrophy type 2 reveals a novel interaction with MBNL1
Yu, Z., Goodman, L. D., Shieh, S.-Y., Ma, M., Teng, X., Zhu, Y., & Bonini, N. M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu507 · Cited by 20
Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy
Callus, E., Bertoldo, E. G., Beretta, M., Boveri, S., Cardani, R., Fossati, B., Brigonzi, E., & Meola, G. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00751 · Cited by 18
Two Enhancers Control Transcription of Drosophila muscleblind in the Embryonic Somatic Musculature and in the Central Nervous System
Bargiela, A., Llamusí, B., Cerro-Herreros, E., & Artero, R. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093125 · Cited by 18
Posttranscriptional Regulation of Insulin Family Ligands and Receptors
Panda, A. C., Grammatikakis, I., Yoon, J., & Abdelmohsen, K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140919202 · Cited by 18
Autism-related traits in myotonic dystrophy type 1 model mice are due to MBNL sequestration and RNA mis-splicing of autism-risk genes
Sznajder, Ł. J., Khan, M., Ciesiołka, A., Tadross, M., Nutter, C. A., Taylor, K., Pearson, C. E., Lewis, M. H., Hines, R. M., Swanson, M. S., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01943-0 · Cited by 19
Self-citation
Systematic identification of post-transcriptional regulatory modules
Khoroshkin, M., Buyan, A., Dodel, M., Navickas, A., Yu, J. X., Trejo, F., Doty, A., Baratam, R., Zhou, S., Lee, S. B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52215-7 · Cited by 18
MBNL1 gene variants as modifiers of disease severity in myotonic dystrophy type 1
Huin, V., Vasseur, F., Schraen‐Maschke, S., Dhaenens, C., Devos, P., Dupont, K., Sergeant, N., Buée, L., Lacour, A., Radvanyi, H., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6740-y · Cited by 17
Towards Understanding RNA-Mediated Neurological Disorders
Duan, R., Sharma, S. K., Xia, Q., Garber, K. B., & Jin, P. (2014) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.08.003 · Cited by 17
CCUG Repeats Reduce the Rate of Global Protein Synthesis in Myotonic Dystrophy Type 2
Schneider‐Gold, C., & Timchenko, L. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.1.19 · Cited by 17
Daunorubicin reduces MBNL1 titration by expanded CUG repeat RNA and rescues cardiac dysfunctions in a Drosophila model of myotonic dystrophy
Chakraborty, M., Sellier, C., Ney, M., Villa, P., Charlet‐Berguerand, N., Artero, R. D., & Llamusí, B. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.032557 · Cited by 17
Bruno-3 regulates sarcomere components expression and contributes to muscle phenotypes of Myotonic dystrophy type 1
Picchio, L., Legagneux, V., Deschamps, S., Renaud, Y., Chauveau, S., Paillard, L., & Jagla, K. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031849 · Cited by 17
Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2)
Santoro, M., Modoni, A., Masciullo, M., et al. (2010) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2010.05.007 · Cited by 17
Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
González-Martínez, I., Cerro-Herreros, E., Moreno, N., García-Rey, A., Espinosa-Espinosa, J., Carrascosa-Sàez, M., Piqueras‐Losilla, D., Arzumanov, A. A., Seoane-Miraz, D., Jad, Y. E., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.09.001 · Cited by 16
Detection of expanded RNA repeats using thermostable group II intron reverse transcriptase
Carrell, S., Tang, Z., Mohr, S., Lambowitz, A. M., & Thornton, C. A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx867 · Cited by 18
Self-citation
Synaptopathy Mechanisms in ALS Caused by C9orf72 Repeat Expansion
Nishimura, A. L., & Arias, N. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.660693 · Cited by 17
Artificial mirtron-mediated gene knockdown: Functional DMPK silencing in mammalian cells
Seow, Y., Sibley, C. R., & Wood, M. J. A. (2012) · RNA · doi:10.1261/rna.030601.111 · Cited by 16
hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologies
Alexander, M. S., Hightower, R. M., Reid, A. L., Bennett, A. H., Iyer, L. K., Slonim, D. K., Saha, M., Kawahara, G., Kunkel, L. M., Kopin, A. S., et al. (2021) · Muscle & Nerve · doi:10.1002/mus.27216 · Cited by 16
Synaptic protein dysregulation in myotonic dystrophy type 1
Hernández‐Hernández, Ó., Sicot, G., Dincã, D. M., Huguet-Lachon, A., Nicole, A., Buée, L., Münnich, A., Sergeant, N., Gourdon, G., & Gomes-Pereira, M. (2013) · Rare Diseases · doi:10.4161/rdis.25553 · Cited by 22
Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2
Cardani, R., Giagnacovo, M., Rossi, G., et al. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.06.435 · Cited by 15
Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration
Jiménez-Marín, A., Diez, I. P., Labayru, G., Sistiaga, A., Caballero, M. C., Andrés‐Benito, P., Sepulcre, J., Ferrer, I., de Munaín, A. L., & Cortés, J. M. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12725 · Cited by 14
Developmental regulation of muscleblind‐like (MBNL) gene expression in the chicken embryo retina
Hu, H., Wahlin, K. J., McNally, M. M., Irving, N. D., & Adler, R. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21408 · Cited by 15
Chronic endoplasmic reticulum stress in myotonic dystrophy type 2 promotes autoimmunity via mitochondrial DNA release
Rösing, S., Ullrich, F., Meisterfeld, S., Schmidt, F., Mlitzko, L., Croon, M., Nattrass, R. G., Eberl, N., Mahlberg, J., Schlee, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45535-1 · Cited by 15
Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1
Sharp, L., Cox, D., & Cooper, T. A. (2019) · Muscle & Nerve · doi:10.1002/mus.26709 · Cited by 14
The Muscular Dystrophies: Distinct Pathogenic Mechanisms Invite Novel Therapeutic Approaches
Sahenk, Z., & Mendell, J. R. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0178-6 · Cited by 15
New Insights Into the Role of RNA-Binding Proteins in the Regulation of Heart Development
Ladd, A. N. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2015.12.009 · Cited by 14
Functions of the Muscleblind-like protein family and their role in disease
Zhou, H., Xu, J., & Pan, L. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02102-5 · Cited by 14
Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model
Neault, N., Ravel‐Chapuis, A., Baird, S. D., Lunde, J. A., Poirier, M. B., Staykov, E., Plaza‐Díaz, J., Medina, G. E., Abadía‐Molina, F., Jasmin, B. J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043794 · Cited by 13
Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients
Nishi, M., Kimura, T., Igeta, M., Furuta, M., Suenaga, K., Matsumura, T., Fujimura, H., Jinnai, K., & Yoshikawa, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0224912 · Cited by 13
Modeling muscle regeneration in RNA toxicity mice
Yadava, R. S., Mandal, M., Giese, J. M., Rigo, F., Bennett, C. F., & Mahadevan, M. S. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab108 · Cited by 13
The Splicing of the Mitochondrial Calcium Uniporter Genuine Activator MICU1 Is Driven by RBFOX2 Splicing Factor during Myogenic Differentiation
Reane, D. V., Cerqua, C., Sacconi, S., Salviati, L., Trevisson, E., & Raffaello, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052517 · Cited by 12
Eosinophilic myositis as first manifestation in a patient with type 2 myotonic dystrophy CCTG expansion mutation and rheumatoid arthritis
Meyer, A., Lannes, B., Carapito, R., et al. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.09.009 · Cited by 13
Biophysical mechanisms for QRS- and QTc-interval prolongation in mice with cardiac expression of expanded CUG-repeat RNA
Tylock, K. M., Auerbach, D. S., Tang, Z. Z., Thornton, C. A., & Dirksen, R. T. (2020) · The Journal of General Physiology · doi:10.1085/jgp.201912450 · Cited by 13
Self-citation
Sequestration of MBNL1 in tissues of patients with myotonic dystrophy type 2
Lukáš, Z., Falk, M., Feit, J., et al. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.03.004 · Cited by 13
Decoding Abnormal Splicing Code in Human Diseases
Ohno, K. (2015) · Journal of Investigative Genomics · doi:10.15406/jig.2015.02.00016 · Cited by 12
Lineage-specific splicing regulation of MAPT gene in the primate brain
Recinos, Y., Bao, S., Wang, X., Phillips, B. L., Yeh, Y.-T., Weyn‐Vanhentenryck, S. M., Swanson, M. S., & Zhang, C. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100563 · Cited by 12
Self-citation
MBNL splicing factors regulate the microtranscriptome of skeletal muscles
Piasecka, A., Szcześniak, M. W., Sekrecki, M., Kajdasz, A., Sznajder, Ł. J., Baud, A., & Sobczak, K. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae774 · Cited by 12
AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action
Cerro-Herreros, E., Núñez‐Manchón, J., Naldaiz‐Gastesi, N., Carrascosa-Sàez, M., García-Rey, A., Piqueras‐Losilla, D., González-Martínez, I., Espinosa-Espinosa, J., Moreno, K., Poyatos‐García, J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn6525 · Cited by 12
Optimization of the Linker Domain in a Dimeric Compound that Degrades an r(CUG) Repeat Expansion in Cells
Benhamou, R. I., Abe, M., Choudhary, S., Meyer, S. M., Angelbello, A. J., & Disney, M. D. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00558 · Cited by 12
Promoter-targeted small RNA duplexes increase MBNL1 transcription and mitigate myotonic dystrophy-associated spliceopathy
Musiała, N., Plewka, P., Jasiok, A., & Stępniak-Konieczna, E. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf756 · Cited by 12
Differential susceptibility of muscles to myotonia and force impairment in a mouse model of myotonic dystrophy
Moyer, M., Berger, D. S., Ladd, A. N., et al. (2011) · Muscle & Nerve · doi:10.1002/mus.21988 · Cited by 11
A rapid immunohistochemical test to distinguish congenital myotonic dystrophy from X-linked myotubular myopathy
Sewry, C. A., Quinlivan, R. C. M., Squier, W., Morris, G. E., & Holt, I. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.10.002 · Cited by 11
Muscleblind-like 1 is required for normal heart valve development in vivo
Coram, R. J., Stillwagon, S. J., Guggilam, A., Jenkins, M. W., Swanson, M. S., & Ladd, A. N. (2015) · BMC Developmental Biology · doi:10.1186/s12861-015-0087-4 · Cited by 11
Self-citation
Overlapping mechanisms of lncRNA and expanded microsatellite RNA
Johnson, S. J., & Cooper, T. A. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1634 · Cited by 11
NKX2-5, a modifier of skeletal muscle pathology due to RNA toxicity
Gladman, J. T., Yadava, R. S., Mandal, M., Yu, Q., Kim, Y. K., & Mahadevan, M. S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu443 · Cited by 11
Cognitive impairment, neuroimaging abnormalities, and their correlations in myotonic dystrophy: a comprehensive review
Wu, Y., Wei, Q., Lin, J., Shang, H., & Ou, R. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1369332 · Cited by 10
Altered drug metabolism and increased susceptibility to fatty liver disease in a mouse model of myotonic dystrophy
Dewald, Z., Adesanya, O. A., Bae, H., Gupta, A. S., Derham, J. M., Chembazhi, U. V., & Kalsotra, A. (2024) · Nature Communications · doi:10.1038/s41467-024-53378-z · Cited by 12
Adult-Onset Myopathy with Constitutive Activation of Akt following the Loss of hnRNP-U
Bagchi, D., Mason, B. D., Baldino, K., Li, B., Lee, E. H., Zhang, Y., Chu, L. K., Raheb, S. E., Sinha, I., & Neppl, R. L. (2020) · iScience · doi:10.1016/j.isci.2020.101319 · Cited by 10
Bruno 1/CELF regulates splicing and cytoskeleton dynamics to ensure correct sarcomere assembly in Drosophila flight muscles
Nikonova, E. V., DeCata, J., Canela-Grimau, M., Barz, C., Esser, A., Bouterwek, J., Roy, A., Gensler, H., Heß, M., Straub, T., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002575 · Cited by 8
The zinc finger domains in U2AF26 and U2AF35 have diverse functionalities including a role in controlling translation
Herdt, O., Reich, S., Medenbach, J., Timmermann, B., Olofsson, D., Preußner, M., & Heyd, F. (2020) · RNA Biology · doi:10.1080/15476286.2020.1732701 · Cited by 10
Micromanaging Alternative Splicing during Muscle Differentiation
Bland, C. S., & Cooper, T. A. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.01.014 · Cited by 10
Congenital Myotonic Dystrophy
Campbell, C. (2012) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.s7-001 · Cited by 10
CaMKIIβ deregulation contributes to neuromuscular junction destabilization in Myotonic Dystrophy type I
Falcetta, D., Quirim, S., Cocchiararo, I., et al. (2024) · Skeletal Muscle · doi:10.1186/s13395-024-00345-3 · Cited by 9
Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1
Hicks, S. M., Frias, J. A., Mishra, S. K., Scotti, M. M., Muscato, D. R., Valero, M. C., Adams, L. M., Cleary, J. D., Nakamori, M., Wang, E. T., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102338 · Cited by 9
Towards the Identification of Biomarkers for Muscle Function Improvement in Myotonic Dystrophy Type 1
Aoussim, A., Légaré, C., Roussel, M., et al. (2023) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-221645 · Cited by 9
Staufen1s role as a splicing factor and a disease modifier in Myotonic Dystrophy Type I
Bondy‐Chorney, E., Parks, T. E. C., Ravel‐Chapuis, A., Jasmin, B. J., & Côté, J. (2016) · Rare Diseases · doi:10.1080/21675511.2016.1225644 · Cited by 9
Sustainable recovery of MBNL activity in autoregulatory feedback loop in myotonic dystrophy
Rogalska, Z., & Sobczak, K. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.10.023 · Cited by 8
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice
Overby, S. J., Cerro-Herreros, E., Espinosa-Espinosa, J., González-Martínez, I., Moreno, N., Fernández‐Costa, J. M., Balaguer-Trias, J., Ramón‐Azcón, J., Pérez‐Alonso, M., Møller, T., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041118 · Cited by 8
RNA mis‐splicing in children with congenital myotonic dystrophy is associated with physical function
Hartman, J. M., Ikegami, K., Provenzano, M., Bates, K., Butler, A., Jones, A. S., Berggren, K. N., Dekdebrun, J. M., McKay, M. J., Baldwin, J., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52224 · Cited by 8
Evoked myotonia can be “dialed‐up” by increasing stimulus train length in myotonic dystrophy type 1
Logigian, E. L., Twydell, P. T., Dilek, N., et al. (2009) · Muscle & Nerve · doi:10.1002/mus.21481 · Cited by 8
Self-citation
Expression Analysis of an Evolutionarily Conserved Alternative Splicing Factor, Sfrs10, in Age-Related Macular Degeneration
Karunakaran, D. K. P., Banday, A. R., Wu, Q., & Kanadia, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075964 · Cited by 8
Self-citation
Transcriptionally correlated subcellular dynamics of MBNL1 during lens development and their implication for the molecular pathology of myotonic dystrophy type 1
Coleman, S., Prescott, A. R., & Sleeman, J. (2014) · Biochemical Journal · doi:10.1042/bj20130870 · Cited by 8
Three-dimensional imaging in myotonic dystrophy type 1
Ballester‐Lopez, A., Núñez‐Manchón, J., Koehorst, E., et al. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000484 · Cited by 8
Cancer Risk in Patients With Fuchs Endothelial Corneal Dystrophy
Xu, T. T., Baratz, K. H., Fautsch, M. P., et al. (2021) · Cornea · doi:10.1097/ico.0000000000002864 · Cited by 7
Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity
Núñez‐Manchón, J., Capó, J., Martínez‐Piñeiro, A., Juanola, E., Pešović, J., Mosqueira‐Martín, L., González-Imaz, K., Maestre-Mora, P., Odria, R., Cerro-Herreros, E., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109930 · Cited by 7
Selective and Reversible Ligand Assembly on the DNA and RNA Repeat Sequences in Myotonic Dystrophy
Krueger, S. B., Lanzendorf, A. N., Jeon, H., & Zimmerman, S. C. (2022) · ChemBioChem · doi:10.1002/cbic.202200260 · Cited by 10
Tibialis anterior muscle needle biopsy and sensitive biomolecular methods: a useful tool in myotonic dystrophy type 1
Iachettini, S., Valaperta, R., Marchesi, A., et al. (2015) · European Journal of Histochemistry · doi:10.4081/ejh.2015.2562 · Cited by 7
Repeat expansion diseases: when a good RNA turns bad
Dickson, A., & Wilusz, C. J. (2010) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.18 · Cited by 7
Deregulation of RNA Metabolism in Microsatellite Expansion Diseases
Misra, C., Lin, F., & Kalsotra, A. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_8 · Cited by 7
Comprehensive pathological and genetic investigation of three young adult myotonic dystrophy type 1 patients with sudden unexpected death
Hata, Y., Ichimata, S., Yoshida, K., Yamaguchi, Y., Hirono, K., & Nishida, N. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11850-8 · Cited by 6
Cardiac Involvement in Myotonic Dystrophy Type 1: Mechanisms, Clinical Perspectives, and Emerging Therapeutic Strategies
Ginjupalli, V. K. M., Reisqs, J., Cupelli, M., Chahine, M., & Boutjdir, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210992 · Cited by 7
Natural Compound Boldine Lessens Myotonic Dystrophy Type 1 Phenotypes in DM1 Drosophila Models, Patient-Derived Cell Lines, and HSALR Mice
Álvarez-Abril, M. C., García-Alcover, I., Colonques-Bellmunt, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129820 · Cited by 6
The Muscleblind-like protein MBL-1 regulates microRNA expression in Caenorhabditis elegans through an evolutionarily conserved autoregulatory mechanism
Verbeeren, J., Teixeira, J., & Garcia, S. M. D. A. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1011109 · Cited by 6
Dynamic Covalent Template-Guided Screen for Nucleic Acid-Targeting Agents
Krueger, S. B., & Zimmerman, S. C. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01086 · Cited by 8
Modified Antisense Oligonucleotides and Their Analogs in Therapy of Neuromuscular Diseases
Konieczny, P., Stępniak-Konieczna, E., & Sobczak, K. (2016) · RNA technologies · doi:10.1007/978-3-319-34175-0_11 · Cited by 6
Myotonic Dystrophy
Nakamori, M., & Takahashi, M. P. (2016) · Springer eBooks · doi:10.1007/978-4-431-55678-7_3 · Cited by 6
Extensive alternative splicing transitions during postnatal skeletal muscle development are required for calcium handling functionsPreprint
Brinegar, A. E., Xia, Z., Loehr, J. A., Li, W., Rodney, G. G., & Cooper, T. A. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/124230 · Cited by 7
MBNL2 enhances cisplatin resistance by regulating apoptosis in ovarian cancer cells
Sung, H. Y., Han, J., Ju, W., et al. (2025) · BMB Reports · doi:10.5483/bmbrep.2024-0167 · Cited by 5
Development of an AAV-delivered microRNA gene therapy for myotonic dystrophy type 1
Tomassy, G. S., Fan, W., Cao, S., Luo, Z., Magli, A., Zhang, T., Boyle, K., Jackson, R., Richards, B., Liu, D., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.08.050 · Cited by 5
Use of HSALR female mice as a model for the study of myotonic dystrophy type I
Carrascosa-Sàez, M., Colom-Rodrigo, A., González-Martínez, I., Pérez-Gómez, R., García-Rey, A., Piqueras‐Losilla, D., Ballestar, A., Llamusí, B., Cerro-Herreros, E., & Artero, R. D. (2025) · Lab Animal · doi:10.1038/s41684-025-01506-7 · Cited by 5
Stress response factors as hub‐regulators of microRNA biogenesis: implication to the diseased heart
Gurianova, V. L., Stroy, D., Ciccocioppo, R., Gašparová, I., Petrovič, D., Souček, M., Dosenko, V., & Kružliak, P. (2015) · Cell Biochemistry and Function · doi:10.1002/cbf.3151 · Cited by 5
Characterisation of Non-Pathogenic Premutation-Range Myotonic Dystrophy Type 2 Alleles
Radvánszky, J., Hýblová, M., Radvanska, E., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173934 · Cited by 5
Disease Phenotypes in a Mouse Model of RNA Toxicity Are Independent of Protein Kinase Cα and Protein Kinase Cβ
Kim, Y. K., Yadava, R. S., Mandal, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163325 · Cited by 5

Authors: Lin, X., Miller, J. W., Mankodi, A., Kanadia, R. N., Yuan, Y., Moxley, R. T., Swanson, M. S., & Thornton, C. A.
Affiliations: University of Rochester Medicine (US)
University of Florida (US)
Corresponding author: Thornton, Charles A.
ORCID: Mankodi, Ami
Kanadia, Rahul N.
Yuan, Yuan
Swanson, Maurice S.
Thornton, Charles A.
Venue: Human Molecular Genetics
Publisher: Oxford University Press (OUP)
Published: 2006-05-22
Volume: 15
Issue: 13
Pages: 2087-2097
ISSN: 0964-6906 (ISSN-L)
1460-2083
DOI: 10.1093/hmg/ddl132
OpenAlex: W2140074138
Semantic Scholar: 1b600bfc756195b662624998312e8d206442a550
Cited by: 510
References: 35
Citations by year: 2026: 19 · 2025: 19 · 2024: 20 · 2023: 19 · 2022: 17 · 2021: 27 · 2020: 29 · 2019: 24 · 2018: 27 · 2017: 19 · 2016: 26 · 2015: 27 · 2014: 37 · 2013: 34 · 2012: 36
FWCI: 9.66
Type: journal article
Language: en
Open access: closed
Locations: Human Molecular Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01ar002250-007)
National Institute of Neurological Disorders and Stroke (NS-48843)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR-48143, R01AR049077, K24AR048143, R01AR046799, AR02250, R01AR046806, AR46806)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords: myotonic dystrophy, MBNL1, MBNL2, CUG repeat expansion, alternative splicing, nuclear foci, skeletal muscle development, myotonic dystrophy type 1, myotonic dystrophy type 2
MeSH terms: Animals, Cell Nucleus, Humans, Mice, Transgenic, Molecular Sequence Data, Myotonic Dystrophy, Time Factors, Immunoblotting, RNA-Binding Proteins, Alternative Splicing, Mice, Knockout, Muscle, Skeletal, Gene Expression Regulation, Developmental, Trinucleotide Repeat Expansion, Reverse Transcriptase Polymerase Chain Reaction, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks